Certara Announces Closing of Public Offering of Common Stock
22 nov. 2021 17h45 HE
|
Certara
PRINCETON, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000...
Global Biosimulation Global Market (2021 to 2030) - Featuring Certara, Dassault and Simulations Plus Among Others
18 nov. 2021 07h28 HE
|
Research and Markets
Dublin, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The "Biosimulation Global Market Report 2021: COVID-19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering. This report...
Certara Appoints James E. Cashman III as Chairman of Board of Directors
08 nov. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that James E. Cashman III, a current Board member, will be...
Certara to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference
03 nov. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William F. Feehery, Chief Executive Officer, and Andrew...
Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award
25 oct. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that its Simcyp COVID-19 Vaccine Model has won an R&D 100...
Certara to Report Third Quarter 2021 Financial Results on November 9th, 2021
19 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that it will release financial results for the third quarter of...
Certara Appoints Drayton T. Virkler as Chief Commercial Officer
05 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the appointment of Drayton T. Virkler to the newly created position...
Certara Completes Acquisition of Pinnacle 21
04 oct. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the completion of the previously announced transaction to acquire...
Certara Launches New Synchrogenix™ Writer Software to Accelerate the Regulatory Submission Process
30 sept. 2021 16h30 HE
|
Certara
PRINCETON, N.J., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced the launch of Synchrogenix™ Writer, a new regulatory SaaS product that expedites the...
Certara Announces New Clinical Science Group and Adds Senior Scientific Experts
22 sept. 2021 08h00 HE
|
Certara
PRINCETON, N.J., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Certara, a global leader in biosimulation, today announced that it is expanding its Integrated Drug Development (IDD) division with a new clinical...